Home
Location
About Us
Programs & Services
Membership
Volunteering at MIFSA
Newsletter
Fact Sheets
Links
Resources for Purchase
Sunflower Shops
Donate
Employment Opportunities
Research Studies
Contact Us

Research Studies

This page displays information about research studies where participation has been invited from MIFSA Membership and people accessing MIFSA services. Should you be interested in being involved in a research study, please read the information advertisements included on this page. Research studies listed on this site have been Ethics Committee approved.

Research Study - Participants wanted
 
Are you a parent and do you also have a mental illness?

 

Parents living with a mental illness and their children are sought for a University of Adelaide study into how parents and children understand parental mental illness.

 

The purpose of this research is to examine the different ways in which children and their parents understand mental illness. Research such as this is needed to give insight into how children might be better educated about mental illness. This research is also important as it will explore parents own views about educating their children.

To participate in this study you will need to be a parent (with at least one child in your care) and have a mental illness (such as anxiety, depression, bipolar disorder, schizophrenia or a personality disorder). Children over the age of 7 years are also invited to participate.

The study involves taking part in a short interview. There are no right or wrong answers and each participant will be paid $20 for their time and effort. All responses will be anonymous.

If you would like to take part in the study, or if you have any questions, please contact Brooke Ferguson on (08) 8303 3818 or brooke.ferguson@adelaide.edu.au


Research Study - Participants wanted
 
Paliperidone ER OROS Trial
 
Research conducted by Glenside Campus Mental Health Service Research Unit. This is a study to determine the oral dose distribution of Paliperidone ER OROS in patients with Schizophrenia.
 
This study is now open to clients coming off Depot. This could make it an ideal opportunity to trial this new capsule.
 
More details can be obtained from Andrew Monkhouse, Clinical Trial Study Coordinator on (08) 8303 1113